References
- Light RW. Update on tuberculous pleural effusion. Respirology 2010;15:451-8. https://doi.org/10.1111/j.1440-1843.2010.01723.x
- Jeon D. Tuberculous pleurisy: an update. Tuberc Respir Dis 2014;76:153-9. https://doi.org/10.4046/trd.2014.76.4.153
- Allen JC, Apicella MA. Experimental pleural effusion as a manifestation of delayed hypersensitivity to tuberculin PPD. J Immunol 1968;101:481-7.
- Leibowitz S, Kennedy L, Lessof MH. The tuberculin reaction in the pleural cavity and its suppression by antilymphocyte serum. Br J Exp Pathol 1973;54:152-62.
- Yamamoto S, Dunn CJ, Willoughby DA. Studies on delayed hypersensitivity pleural exudates in guinea-pigs. II. The interrelationship of monocytic and lymphocytic cells with respect to migration activity. Immunology 1976;30:513-9.
- Lee JY. Diagnosis and treatment of extrapulmonary tuberculosis. Tuberc Respir Dis 2015;78:47-55. https://doi.org/10.4046/trd.2015.78.2.47
- Gakis C. Adenosine deaminase (ADA) isoenzymes ADA1 and ADA2: diagnostic and biological role. Eur Respir J 1996;9:632-3. https://doi.org/10.1183/09031936.96.09040632
- Kashyap RS, Deshpande PS, Nayak AR, Purohit HJ, Taori GM, Daginawala HF. Adenosine deaminase activity in the supernatant of monocytes infected with Mycobacterium tuberculosis . Int J Integr Biol 2007;1:61-4.
- Kim CH, Lee J, Lee J, Cliff JM, Toulza F, Smith S, et al. Mycobacterial load affects adenosine deaminase 2 levels of tuberculous pleural effusion. J Infect 2015;71:488-91. https://doi.org/10.1016/j.jinf.2015.05.015
- Hasan Z, Jamil B, Ashraf M, Islam M, Dojki M, Irfan M, et al. Differential live Mycobacterium tuberculosis -, M. bovis BCG-, recombinant ESAT6-, and culture filtrate protein 10-induced immunity in tuberculosis. Clin Vaccine Immunol 2009;16:991-8. https://doi.org/10.1128/CVI.00091-09
- Hasan Z, Schlax C, Kuhn L, Lefkovits I, Young D, Thole J, et al. Isolation and characterization of the mycobacterial phagosome: segregation from the endosomal/lysosomal pathway. Mol Microbiol 1997;24:545-53.
- Wongtim S, Silachamroon U, Ruxrungtham K, Udompanich V, Limthongkul S, Charoenlap P, et al. Interferon gamma for diagnosing tuberculous pleural effusions. Thorax 1999;54:921-4. https://doi.org/10.1136/thx.54.10.921
- Piras MA, Gakis C, Budroni M, Andreoni G. Adenosine deaminase activity in pleural effusions: an aid to differential diagnosis. Br Med J 1978;2:1751-2.
- Gakis C, Calia G, Naitana A, Pirino D, Serru G. Serum adenosine deaminase activity in HIV positive subjects: a hypothesis on the significance of ADA2. Panminerva Med 1989;31:107-13.
- Gakis C, Cappio-Borlino A, Pulina G. Enzymes (isoenzyme system) as homeostatic mechanisms the isoenzyme (ADA2) of adenosine deaminase of human monocytes-macrophages as a regulator of the 2'deoxyadenosine. Biochem Mol Biol Int 1998;46:487-94.
- Tay TR, Tee A. Factors affecting pleural fluid adenosine deaminase level and the implication on the diagnosis of tuberculous pleural effusion: a retrospective cohort study. BMC Infect Dis 2013;13:546. https://doi.org/10.1186/1471-2334-13-546
- Lee SJ, Kim HS, Lee SH, Lee TW, Lee HR, Cho YJ, et al. Factors influencing pleural adenosine deaminase level in patients with tuberculous pleurisy. Am J Med Sci 2014;348:362-5. https://doi.org/10.1097/MAJ.0000000000000260
- Zavialov AV, Gracia E, Glaichenhaus N, Franco R, Lauvau G. Human adenosine deaminase 2 induces differentiation of monocytes into macrophages and stimulates proliferation of T helper cells and macrophages. J Leukoc Biol 2010;88:279-90. https://doi.org/10.1189/jlb.1109764
- Lugo-Villarino G, Verollet C, Maridonneau-Parini I, Neyrolles O. Macrophage polarization: convergence point targeted by Mycobacterium tuberculosis and HIV. Front Immunol 2011;2:43.
- Verreck FA, de Boer T, Langenberg DM, Hoeve MA, Kramer M, Vaisberg E, et al. Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria. Proc Natl Acad Sci U S A 2004;101:4560-5. https://doi.org/10.1073/pnas.0400983101
Cited by
- Deficiency of Adenosine Deaminase 2 (DADA2): Updates on the Phenotype, Genetics, Pathogenesis, and Treatment vol.38, pp.5, 2018, https://doi.org/10.1007/s10875-018-0525-8
- Serum Biomarker Profile Including CCL1, CXCL10, VEGF, and Adenosine Deaminase Activity Distinguishes Active From Remotely Acquired Latent Tuberculosis vol.12, pp.None, 2017, https://doi.org/10.3389/fimmu.2021.725447